{"product_id":"the-ldn-book-how-a-little-known-generic-drug-low-dose-naltrexone-could-revolutionize-treatment-for-autoimmune-diseases-cance-9781603586641","title":"The Ldn Book: How a Little-Known Generic Drug -- Low Dose Naltrexone -- Could Revolutionize Treatment for Autoimmune Diseases, Cance","description":"\u003cp\u003e\u003cstrong\u003eCould a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?\u003c\/strong\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\"\u003c\/strong\u003e\u003cstrong\u003e[LDN] raises hopes of reversing memory loss in old age.\"--\u003cem\u003ethe Guardian\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003eOver 30,000 copies sold!\u003c\/strong\u003e\u003c\/p\u003e \u003cp\u003eLow Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects.\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003eSo why has it languished in relative medical obscurity?\u003c\/strong\u003e\u003cbr\u003e \u003cbr\u003e \u003cem\u003eThe LDN Book\u003c\/em\u003e explains: \u003c\/p\u003e \u003cul\u003e \u003cli\u003eThe drug's origins\u003c\/li\u003e \u003cli\u003eIts primary mechanism\u003c\/li\u003e \u003cli\u003eThe latest research from practicing physicians and pharmacists\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003eCompiled by Linda Elsegood of The LDN Research Trust--the world's largest LDN charity organization with over 19,000 members worldwide--the book features ten chapters contributed by medical professionals on LDN's efficacy and two patient-friendly appendices. \u003c\/p\u003e \u003cp\u003e\u003cstrong\u003e\u003cem\u003eThe LDN Book\u003c\/em\u003e is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.\u003c\/strong\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAbout the Author\u003c\/b\u003e\u003cbr\u003e\u003cb\u003e\u003ci\u003eElsegood, Linda:\u003c\/i\u003e\u003c\/b\u003e - \u003cp\u003eLinda Elsegood is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of \u003cem\u003eThe LDN Book\u003c\/em\u003e. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.\u003c\/p\u003e","brand":"Chelsea Green Publishing Company","offers":[{"title":"Default Title","offer_id":50855945404690,"sku":"9781603586641","price":20.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0831\/4771\/8930\/files\/img_0607e783-7b4a-4010-8d71-effd1dbc659b.jpg?v=1737489911","url":"https:\/\/surprise-castle.myshopify.com\/products\/the-ldn-book-how-a-little-known-generic-drug-low-dose-naltrexone-could-revolutionize-treatment-for-autoimmune-diseases-cance-9781603586641","provider":"Surprise Castle","version":"1.0","type":"link"}